AIM Suspension - 4D Pharma PLC (1476Q)
24 Juni 2022 - 1:30PM
UK Regulatory
TIDMDDDD
RNS Number : 1476Q
AIM
24 June 2022
NOTICE
24/06/2022 12:30pm
TEMPORARY SUSPENSION OF TRADING ON AIM
4D PHARMA PLC
At the request of the Company trading on AIM for the
under-mentioned securities has been temporarily suspended from
24/06/2022 12:30pm, pending an announcement.
ORDINARY SHARES OF 0.25P EACH, FULLY PAID (BJL5BR0)
(GB00BJL5BR07)
If you have any queries relating to the above, please contact
the company's nominated adviser on +44 (0)20 7496 3000.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
EXCEAFKLAFSAEFA
(END) Dow Jones Newswires
June 24, 2022 07:30 ET (11:30 GMT)
4d Pharma (LSE:DDDD)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
4d Pharma (LSE:DDDD)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
Echtzeit-Nachrichten über 4d Pharma Plc (Londoner Börse): 0 Nachrichtenartikel
Weitere 4d Pharma Plc News-Artikel